What Health Professionals Are Saying About the Isagenix Clinical Study
As you may have heard (or read here and here), a clinical study showing the Isagenix system to be superior to a leading “heart healthy” diet for weight loss and visceral fat loss was recently published in two prestigious peer-reviewed publications. Isagenix Chief Science Officer Suk Cho, Ph.D., had a chance to get reactions about the results from some of the revered health professionals of Isagenix at this year’s New Year’s Kick Off (NYKO) event. Here are some quotes from the event:
“It was absolutely astonishing. We had seen the results in the real world, but the thing that really struck me was the visceral fat loss. As physicians we know that visceral fat is a major predictor of mortality and disease… [In many studies] there is argument over what is real and what is not. But [Isagenix] used all physiological measurements, which means they measured real things that you can’t fake—the fat loss was measured by water submersion, you had MRI studies, you took blood work. It was so well-documented that it actually embarrassed the heart-healthy diet.” Paul Anderson, M.D., D.A.P.M.
“I was so very impressed and I am so proud to be a part of the group that has produced this research and get two publications in really good peer-reviewed journals. That says something about Isagenix that you will not find in any other company that I know of, any other network marketing company, and that’s just the beginning.” Michael Colgan, Ph.D.
“This study is a big deal, guys. I know a little bit about clinical research. To reiterate what Dr. Anderson was saying, this was well-designed, at a major research facility, by a renowned researcher that is published. The results weren’t just good, they kicked butt. I mean, really, they were impressive… [The results] are nicely summarized for you in a flyer. When you are talking to your physician, just ask him if he has any patients looking for weight loss and what is he currently doing. Would he be interested to see the results of a clinical study that was just done by a nutritional company? And see if he’ll take a look at it. I think it will carry a lot of clout.” Nick Messina, M.D.